Century Therapeutics, Inc. announced it will present at the ASGCT 28th Annual Meeting, taking place from May 13-17, 2025, in New Orleans. The company will showcase data related to its preclinical cell ...
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine ...
Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of ...
Five presentations of clinical and preclinical data will showcase the company's advancements in iPSC-derived cellular immunotherapies at a prestigious annual meeting, indicating strong scientific ...
The success of a vaccine, a gene editing design for an untreated disease, or achieving cell engraftment after several attempts, comes from years of accumulated basic science studies, thousands of ...
Latus founder Beverly Davidson, Ph.D., awarded the ASGCT Outstanding Achievement Award – the Society’s highest honor Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad ...
Asgard Therapeutics will present new preclinical data on its lead asset AT‑108 in an oral presentation at the ASGCT Annual Meeting, taking place from 11–15 May in Boston. AT‑108 is a first‑in‑class, ...
One abstract accepted as platform presentation in prestigious Presidential Symposium, demonstrating potent combination of epigenetic regulation and capsid delivery technology in treating prion disease ...
RICHMOND, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results